Strategy for improvement of graft survival in kidney recipients of nonrelated living donors.
Távora
E R
ER
Department of Organ Transplantation, Hospital Felicio Rocho, Belo Horizonte, Brazil.
Lasmar
E P
EP
Vilaca
S S
SS
Figueiró
J V
JV
Bamberg
A
A
Rocha
L M
LM
Costa
M M
MM
Bicalbo
O
O
Souza
E
E
Machado
R
R
D000017:ABO Blood-Group System; D000293:Adolescent; D000300:Adoption; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005190:Family; D005260:Female; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008393:Marriage; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D014019:Tissue Donors
D000017:ABO Blood-Group System; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone